Oric Pharmaceuticals, Inc. (ORIC)

Typically moves ±5.64% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-08-12 ESTIMATED

Across 25 earnings reports since May 20, 2020, Oric Pharmaceuticals, Inc. (ORIC) has a clear post-earnings pattern. It moves ±5.64% on average after reporting and finishes higher 68.0% of the time. Its largest post-earnings gain was +14.6% (Feb 23, 2026) and its largest decline was -28.74% (Mar 21, 2022). The next earnings report is predicted for 2026-08-12 (estimated).

Earnings reactions

How ORIC moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±5.64%

Positive %

68.0%

Negative %

32.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
May 04, 2026	☽ POST	-0.26%	open_in_new
Feb 23, 2026	☽ POST	+14.6%	open_in_new
Nov 13, 2025	☽ POST	+0.49%	open_in_new
Aug 12, 2025	☽ POST	+3.26%	open_in_new
May 05, 2025	☽ POST	-11.58%	open_in_new
Feb 18, 2025	☽ POST	+1.15%	open_in_new
Nov 12, 2024	☽ POST	+0.1%	open_in_new
Aug 12, 2024	☽ POST	+6.76%	open_in_new
May 06, 2024	☽ POST	+2.56%	open_in_new
Mar 11, 2024	☽ POST	-4.47%	open_in_new
Nov 06, 2023	☽ POST	-0.72%	open_in_new
Aug 10, 2023	☽ POST	+10.97%	open_in_new
May 08, 2023	☽ POST	-2.49%	open_in_new
Mar 16, 2023	☽ POST	-8.62%	open_in_new
Nov 07, 2022	☽ POST	+3.69%	open_in_new
Aug 11, 2022	☽ POST	+4.54%	open_in_new
May 09, 2022	☽ POST	+5.19%	open_in_new
Mar 21, 2022	☽ POST	-28.74%	open_in_new
Nov 08, 2021	☽ POST	+8.4%	open_in_new
Aug 10, 2021	☽ POST	+6.98%	open_in_new
May 06, 2021	☽ POST	+0.04%	open_in_new
Mar 23, 2021	☽ POST	+0.17%	open_in_new
Nov 05, 2020	☽ POST	-0.04%	open_in_new
Aug 05, 2020	☽ POST	+14.07%	open_in_new
May 20, 2020	☽ POST	+1.18%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.64%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 17 →

Funds holding

$253186536

Total value held

Buying

11 added · 5 reduced

Blackrock, Inc.

$75824274 +1.86%

State Street Corp

$46906823 -13.06%

Pfizer Inc

$43978494 Held

Morgan Stanley

$21317567 +40.91%

Goldman Sachs Group Inc

$18697271 -23.90%

SEC Filing Types

description SCHEDULE 13G/A

13 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260708	open_in_new SEC.gov
144	20260706	open_in_new SEC.gov
144	20260706	open_in_new SEC.gov
8-K	20260622	open_in_new SEC.gov
SCHEDULE 13G/A	20260515	open_in_new SEC.gov
SCHEDULE 13G/A	20260515	open_in_new SEC.gov
SCHEDULE 13G/A	20260515	open_in_new SEC.gov
SCHEDULE 13G	20260515	open_in_new SEC.gov
10-Q	20260504	open_in_new SEC.gov
8-K	20260504	open_in_new SEC.gov

Frequently asked about ORIC earnings

When does Oric Pharmaceuticals, Inc. report earnings next? expand_more

Oric Pharmaceuticals, Inc. (ORIC)'s next earnings date is estimated for 2026-08-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does ORIC stock move after earnings? expand_more

Over 25 reports, ORIC has moved an average of ±5.64% the session after earnings, closing higher 68.0% of the time.

What was ORIC's biggest post-earnings move? expand_more

ORIC's largest post-earnings gain on record was +14.6% on Feb 23, 2026, and its largest decline was -28.74% on Mar 21, 2022.

Where can I find Oric Pharmaceuticals, Inc.'s SEC filings? expand_more

All of Oric Pharmaceuticals, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.